Clinical Profile of Suvorexant in a Real-World Setting: Results from a Post-Marketing Survey in Japan

被引：0
|
作者：
Sano, H. [1 ]
Asai, Y. [2 ]
Miyazaki, M. [2 ]
Iwakura, M. [2 ]
Maeda, M. Y. [2 ]
Hara, M. M. [2 ]
机构：
[1] MSD KK, CNS Med Informat, Med Affairs, Tokyo, Japan
[2] MSD KK, Drug Safety Post Mkt, Tokyo, Japan
来源：
JOURNAL OF SLEEP RESEARCH | 2018年 / 27卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P074
引用
收藏
页数：5
相关论文
共 50 条
  • [1] Real-world evidence of the safety and efficacy profile of suvorexant in elderly patients with insomnia: a sub-analysis of the post-marketing drug-use results survey in Japan
    Takeuchi, Yuko
    Sano, Hideki
    Asai, Yuko
    Miyazaki, Makoto
    Iwakura, Mika
    Maeda, Yoshikazu
    CURRENT MEDICAL RESEARCH AND OPINION, 2020, 36 (03) : 465 - 471
  • [2] Clinical outcomes with daptomycin: a post-marketing, real-world evaluation
    Sakoulas, G.
    CLINICAL MICROBIOLOGY AND INFECTION, 2009, 15 : 11 - 16
  • [3] Real-world safety of nusinersen in Japan: results from an interim analysis of a post-marketing surveillance and safety database
    Wataya, Takafumi
    Takasaki, Sakura
    Hoshino, Misuzu
    Makioka, Haruki
    Nakamura, Genshu
    Matsuda, Naoto
    INTERNATIONAL JOURNAL OF NEUROSCIENCE, 2023, 133 (08) : 851 - 863
  • [4] SAFETY AND EFFICACY OF SUVOREXANT IN A REAL WORLD SETTING: RESULTS FROM THE DRUG USE-RESULTS SURVEY IN JAPAN
    Miyazaki, M.
    Asai, Y.
    Iwakura, M.
    Hara, M.
    SLEEP, 2018, 41 : A167 - A167
  • [5] Real-World Safety and Effectiveness of Adalimumab in Patients with Juvenile Idiopathic Arthritis: Results from a Post-Marketing Surveillance in Japan
    Takei, Syuji
    Iwata, Naomi
    Kobayashi, Ichiro
    Igarashi, Toru
    Yoshinaga, Yoko
    Matsubara, Naoko
    Sunaga, Naomi
    Ito, Ayumi
    Yokota, Shumpei
    ARTHRITIS & RHEUMATOLOGY, 2018, 70
  • [6] SAFETY AND EFFICACY OF SUVOREXANT IN A REAL WORLD SETTING: INTERIM RESULTS FROM THE DRUG USE-RESULTS SURVEY IN JAPAN
    Miyazaki, M.
    Asai, Y.
    Iwakura, M.
    Hara, M.
    SLEEP MEDICINE, 2017, 40 : E229 - E229
  • [7] Safety profile and clinical course of patients with insomnia administered suvorexant by initial treatment status in a post-marketing survey
    Sano, Hideki
    Asai, Yuko
    Miyazaki, Makoto
    Iwakura, Mika
    Maeda, Yoshikazu
    Hara, Mitsuyoshi
    EXPERT OPINION ON DRUG SAFETY, 2019, 18 (11) : 1109 - 1118
  • [8] Real-world data on ranibizumab for myopic choroidal neovascularization due to pathologic myopia: results from a post-marketing surveillance in Japan
    Ohno-Matsui, Kyoko
    Suzaki, Makoto
    Teshima, Rie
    Okami, Nina
    EYE, 2018, 32 (12) : 1871 - 1878
  • [9] Safety and effectiveness of everolimus in maintenance kidney transplant patients in the real-world setting: results from a 2-year post-marketing surveillance study in Japan
    Hayase, Naomi
    Yamada, Mariko
    Kaneko, Shuhei
    Watanabe, Yoko
    CLINICAL AND EXPERIMENTAL NEPHROLOGY, 2021, 25 (06) : 660 - 673
  • [10] Real-world data on ranibizumab for myopic choroidal neovascularization due to pathologic myopia: results from a post-marketing surveillance in Japan
    Kyoko Ohno-Matsui
    Makoto Suzaki
    Rie Teshima
    Nina Okami
    Eye, 2018, 32 : 1871 - 1878
12345